More on MED
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $10.80 |
|
|||
| Open | $10.63 | ||||
| 52 Wk High | $42.14 | ||||
| 52 Wk Low | $27.12 | ||||
| Day High | $10.80 | ||||
| Day Low | $10.50 | ||||
| P/E | 7.28 | ||||
| EPS | $1.48 | ||||
| Volume | 138,251 | ||||
- Medifast makes OPTAVIA eligible for HSA and FSA reimbursement
- Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
- Medifast (MED) PT Lowered to $12 at Stephens
- Form 10-K MEDIFAST INC For: Dec 31
- Form 8-K MEDIFAST INC For: Feb 17
- Medifast (MED) Misses Q4 EPS by 120c
- Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
- Form SCHEDULE 13G/A MEDIFAST INC Filed by: SUSQUEHANNA SECURITIES, LLC
- Form SCHEDULE 13G/A MEDIFAST INC Filed by: CHARLES SCHWAB INVESTMENT MANAGEMENT INC
- Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
Entities mentioned with MED
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Twitter | View Related Stories »
- D.A. Davidson | View Related Stories »
- 13D | View Related Stories »
- Stock Buyback | View Related Stories »
- Show More...
